Web18 feb. 2024 · Zantac® Lawsuit. Thousands of people have filed Zantac lawsuits, claiming the heartburn drug caused their cancer. Recently, tests identified a cancer-causing substance known as NDMA in the drug. NDMA was also found in ranitidine, the generic form of Zantac. Plaintiffs claim the carcinogen-containing drug caused a variety of cancers. Web20 jul. 2024 · Johnson & Johnson will pay up to $5 billion over nine years, with up to $3.7 billion paid during the first three years. Of the $26 billion, about $2 billion will go towards lawyers' fees and other...
Xarelto Lawsuit 2024 Updates and Settlement Amounts
Web23 okt. 2024 · Here’s a quick look at some of the drug lawsuits with the highest payouts of all time: GlaxoSmithKline, $3 billion (2012) Pfizer, $2.3 billion (2009) Johnson & Johnson, $2.2 billion (2013) Abbot Labs, $1.5 billion (2012) Eli Lilly & Company, $1.415 billion (2009) TAP Pharmaceutical Products, $875 million (2001) Amgen, $762 million (2012) Web3 jan. 2024 · The three major drug distributors – Cardinal Health, McKesson, and AmerisourceBergen – agreed to pay $215 million, while Teva, a generic drug … medley boney m
4 drug companies agree to pay $26 billion to resolve opioid lawsuits
Web5 jul. 2024 · The Drug: With more than 20,000 Xarelto lawsuits filed against Johnson & Johnson, this prescription blood thinner is one of the largest subjects of litigation in this group. As one of the first of a new generation of anticoagulants, Johnson & Johnson failed to develop an antidote for Xarelto when it was introduced, leaving patients without a way … Web2 okt. 2024 · Historically, the Zantac heartburn drug had been linked to minor side effects like insomnia, headaches, and fatigue. So those minor side effects alone would not warrant a lawsuit. However, things changed with researchers discovered the link between the carcinogenic NDMA in Ranitidine and multiple types of cancer in 2024. Web20 jul. 2024 · Johnson & Johnson will pay up to $5 billion over nine years, with up to $3.7 billion paid during the first three years. Of the $26 billion, about $2 billion will go towards … naion therapie